Skip to main content
Access every election story that matters
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Access every election story that matters
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
// //

The COVID-19 death rate for people in the Indonesian capital of Jakarta who were not vaccinated was more than three times higher than those who were, according to new health ministry data.

The mortality rate of those who were not vaccinated was 15.5% compared with 4.1% for those who had received two shots of either the Sinovac or AstraZeneca vaccine, according to data from state hospitals and almost 68,000 patients in Jakarta from May to July.

The Southeast Asian country has been overwhelmed in recent months by a rapid spike in coronavirus cases, and on Wednesday it passed a grim milestone, recording a total of more than 100,000 deaths from COVID-19.

Story continues below advertisement

Global data on vaccinated versus unvaccinated deaths is not easily available but Dr. Ines Atmosukarto, a molecular biologist who works on vaccine development, said the data was further evidence of the importance of vaccination.

“This supports the proposition that two doses of vaccines reduces the chance of dying for those infected and requiring hospitalization,” she said, adding that the data lacked detail about the age, comorbidity and period of observation of the patients.

Separately, data from the town of Banyuwangi on Java island, showed that 93% of COVID-19 patients who died from March to July were not vaccinated, while 6% per cent had received a first dose, and 1% had been fully vaccinated.

Sinovac and AstraZeneca vaccines were also the vaccines predominately administered in that area.

Siti Nadia Tarmizi, a senior health ministry official, said the data could help combat vaccine hesitancy in Indonesia.

In Indonesia, 18% of the population have had one dose of a vaccine, while 8% are fully vaccinated, according to health ministry data. Indonesia has had 100,600 deaths.

By comparison, in India 27.7% of the population have had one dose of a vaccine and 7.8 % are fully vaccinated, according to according to government data and research by Reuters. India has had 425,700 deaths.

Story continues below advertisement

Grappling with the spread of the highly transmissible Delta variant that was first identified in India, Indonesia has quickly become Asia’s coronavirus epicentre, now recording more than 3.5 million cases in total since the start of the pandemic.

But as cases have begun to drop in Jakarta and some areas on Java, with the health minister saying this week the country has reached the peak of its second wave, concerns remain that Delta could still ravage far-flung regions ill-equipped to handle a health crisis.

Irma Hidayana, a public health expert and co-founder of independent data initiative Lapor COVID-19 said that vaccine distribution issues, including infrastructure and data, as well as vaccine hesitancy, had hampered the government’s vaccine rollout.

“The ministry of health needs to have well planned vaccine distribution that ensures all vulnerable people are top priority,” she said, “The government must ensure that vaccines are evenly and equally distributed.”

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies